Skip to main content

Table 6 HER2 status and median overall survival

From: Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342

Method for ascertaining HER2 HER2 positive HER2 negative Log-rank P value
CB11 11.3 months 13.1 months 0.14
FISH 10.9 months 13.1 months 0.26
HercepTest: 2–3 versus 0–1 11.5 months 13.2 months 0.84
  1. FISH, fluorescence in situ hybridization.